Home
NewsNewsOTO Launches Fertility Diagnostic Wearable featuring Cira, new patented biometric and AI-powered wrist-worn biosensor technology designed to decode reproductive preparedness with precision and personalized insights.
OTO Fertility, which is a digital health platform that has been developed by OTO Coach, is going ahead and redefining the gamut of reproductive care through patented biometric and AI-powered tech that is designed to bring in much clarity and accuracy, along with confidence, when it comes to fertility treatment. At the Consumer Electronic Show - CES 2026 that was held in Las Vegas, OTO Launches Fertility Diagnostic Wearable called Cira™, which is its newest wrist-worn fertility biosensor, hence marking a prominent advancement in how the patients as well as clinics understand and also support reproductive preparedness.
Built in order to support every path to parenthood, right from natural conception to the spectrum of IVF as well as IUI, the OTO Fertility solution mixes real-time physiological data along with exact guidance that aids the patients as well as fertility care teams to make better-informed decisions at times that matter most.
The technology by OTO is rooted in over 40 years of bioscience as well as space medicine, originally created by NASA for astronauts and thereafter refined for elite human performance. Due to the launch of Cira, the patented biometric and AI-powered tech, this level of physiological accuracy is now rolled out by way of a comfortable wristband paired along with the FDA-approved app by OTO. Together, they track over fifty biometric markers, and that too only in minutes, which includes heart rate variability, nervous system regulation along with stress response, thereby translating intricate biology into a much clearer and actionable OTO Fertility Index.
This kind of index identifies when the body happens to be in an optimized fertility zone and offers insight that goes far beyond the traditional fertility elements of measure like age, BMI, or even AMH. For the very first time, women can go on to clearly witness when their body is actually ready to conceive, thereby restoring that much-needed autonomy and confidence along with control in a process that in the past has been defined by uncertainty.
Until now, fertility care has been present without any kind of visibility when it comes to the most fundamental factor, and that is how the body is responding to and also recovering from the stress in real time, remarked the Founder and CEO of OTO, Caleb Evans. Due to Cira as well as the OTO Fertility platform app, patients gain that much-needed clarity and agency, while the clinicians, on the other hand, gain a crucial new layer of that physiological context to guide care. They do not replace the currently existing fertility protocols, but they make them much smarter and safer as well as proactive.
It is well to be noted that internationally, one in every six women goes on to experience infertility, and in spite of decades of innovation, fertility treatment success rates have actually plateaued. The fact is that when we talk of fertility care, time happens to be that one resource that cannot be replaced. Every cycle along with intervention, and also every decision, goes on to carry emotional, physical as well as financial weight. OTO Fertility can be regarded as the first platform that is built to help decrease that avoidable loss along with poorly timed interventions, and at the same time the risk of proceeding sans comprehending if the body is actually prepared, thereby bringing a new benchmark of care within the reproductive medicine space.
It is worth noting that OTO Launches Fertility Diagnostic Wearable Cira wristband and the OTO Fertility platform, along with the OTO Life app, which are going to be showcased at CES 2026 to be held in Las Vegas at the Venetian, with availability expanding well throughout North America via partner fertility clinics and clinical programs that are presently underway.
Abu Dhabi University and FertiClinic Group have joined forces to establish the FertiClinic Reproductive Research Lab, an advanced reproductive research lab in Abu Dhabi housing IVF, andrology, and cryopreservation facilities. The partnership supports UAE national priorities, bridges academic and clinical expertise, and advances fertility innovation across the region.
NHS Kent and Medway has overhauled its fertility funding policy in a move that sees NHS cuts IVF access for thousands of patients. Effective 1 April 2026, the eligible age ceiling drops from 40 to 38, funded cycles fall from two to one, and embryo transfers are capped at two.
ASEAN's First Telemedicine IVF by Inspire IVF introduces a new era of remote fertility care. Combining AI technology with expert consultation, the platform enables global access, real-time monitoring, and personalised treatment planning, positioning Thailand as a leading hub for fertility services and advancing digital transformation in reproductive healthcare.
CSG.BIO has gone ahead with the acquisition of Hanabusa IVF, Asian Egg Bank, thereby making it a world leader in reproductive medicine and cutting-edge clinics with enhanced patient reach and advanced laboratory capabilities.
Wisconsin lawmakers from both parties are proposing bills to reduce IVF treatment costs. Republicans suggest a $5,000 tax credit for expenses, while Democrats want mandatory insurance coverage. With IVF cycles costing $20,000-$30,000 and 170,000 residents facing infertility, both parties seek affordable solutions through different approaches.
The AI-specialized Infertility Center, which is the largest in Asia, is open in Magok, Seoul and has begun its full-scale medical services from November 17 thereby marking the new era when it comes to fertility in the region.
Alife Health secured CE Mark approval for its AI-powered embryo selection tool, Embryo Predict, under EU MDR, expanding its fertility technology presence across Europe.
